Avanos Medical, Inc. (NYSE:AVNS) Short Interest Update

Avanos Medical, Inc. (NYSE:AVNS) saw a large decline in short interest during the month of December. As of December 31st, there was short interest totalling 681,400 shares, a decline of 6.4% from the December 15th total of 727,700 shares. Based on an average trading volume of 349,300 shares, the short-interest ratio is currently 2.0 days. Approximately 1.5% of the company’s stock are sold short.

Avanos Medical Stock Performance

Shares of AVNS traded down $0.11 during mid-day trading on Monday, hitting $15.94. 290,991 shares of the company traded hands, compared to its average volume of 429,124. Avanos Medical has a 1 year low of $14.98 and a 1 year high of $25.36. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.46 and a current ratio of 2.22. The stock has a 50-day moving average price of $17.42 and a two-hundred day moving average price of $20.80. The stock has a market cap of $732.60 million, a price-to-earnings ratio of 46.88 and a beta of 0.99.

Hedge Funds Weigh In On Avanos Medical

Institutional investors and hedge funds have recently modified their holdings of the company. The Manufacturers Life Insurance Company increased its position in shares of Avanos Medical by 3.6% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 17,137 shares of the company’s stock valued at $341,000 after purchasing an additional 590 shares during the last quarter. KBC Group NV increased its holdings in Avanos Medical by 63.0% during the third quarter. KBC Group NV now owns 2,833 shares of the company’s stock valued at $68,000 after buying an additional 1,095 shares during the last quarter. New York State Teachers Retirement System raised its position in Avanos Medical by 2.0% in the third quarter. New York State Teachers Retirement System now owns 72,294 shares of the company’s stock worth $1,737,000 after acquiring an additional 1,388 shares during the period. Quarry LP purchased a new position in shares of Avanos Medical during the 3rd quarter worth $42,000. Finally, Foundry Partners LLC grew its position in shares of Avanos Medical by 1.1% during the 3rd quarter. Foundry Partners LLC now owns 163,030 shares of the company’s stock valued at $3,918,000 after acquiring an additional 1,800 shares during the period. 95.17% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Separately, StockNews.com cut Avanos Medical from a “strong-buy” rating to a “buy” rating in a research report on Sunday, November 3rd.

About Avanos Medical

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.